Block of hERG K+ channel by classic histamine H1 receptor antagonist chlorpheniramine

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 3, 2009, Pages 215-220

  Hong, Hee Kyung ^a   Jo, Su Hyun ^a  

^a Kangwon National University College of Medicine   (South Korea)

Author keywords

Antihistamine; Chlorpheniramine; HERG channel; Rapidly activating delayed rectifier K+ channel

Indexed keywords

ALANINE; CHLORPHENIRAMINE; PHENYLALANINE; POTASSIUM CHANNEL HERG; TYROSINE;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; FEMALE; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PROTEIN DOMAIN; QT PROLONGATION; RECEPTOR BLOCKING; XENOPUS LAEVIS;

EID: 67651018283     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.3.215     Document Type: Article

References (26)

1. Arcangeli A, Becchetti A, Mannini A, Mugnai G, De Pilippi P, Tarone G, Del Bene MR, Barletta E, Wanke E, Olivotto M. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol 122: 1131-1143, 1993. (Pubitemid 23254179)
2. + current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (Lond) 489: 455-471, 1995. (Pubitemid 26009425)
3. Baselt R, Cravey R. Disposition of toxic drugs and chemicals in man. 4th ed. Foster City, CA: Chemical Toxicology Institute, 1995.
4. + channels: spike-frequency adaptation. J Physiol (Lond) 501: 313-318, 1997. (Pubitemid 27280806)
5. + channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J Pharmacol Exp Ther 313: 888-895, 2005.
6. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 292: 60, 1986.
7. Goldberg MJ, Spector R, Chiang CK. Transport of diphenhydramine in the central nervous system. J Pharmacol Exp Ther 240: 717-722, 1987. (Pubitemid 17043566)
8. Hestand HE, Teske DW. Diphenhydramine hydrochloride intoxication. J Pediatr 90: 1017-1018, 1977.
9. Huang SM, Chiou WL. Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration. J Pharmacokinet Biopharm 9: 711-723, 1981. (Pubitemid 12184819)
10. Hung YM, Chang JC. Weight-reducing regimen associated with polymorphic ventricular tachycardia. Am J Emerg Med 24: 714-716, 2006.
11. Katzung BG. Histamine, Serotonin, and the ergot alkaloids. Basic and Clinical Pharmacology, 9th ed, McGraw-Hill, San Francisco, p263-268, 2003.
12. 1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles. Arch Int Pharmacodyn Ther 331: 59-73, 1996. (Pubitemid 26328476)
13. Mitcheson JS. Drug binding to HERG channels: evidence for a "non-aromatic" binding site for fluvoxamine. Br J Pharmacol 139: 883-884, 2003.
14. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97: 12329-12333, 2000. (Pubitemid 30815185)
15. Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 58: 32-45, 2003. (Pubitemid 36351620)
16. Reed D. A fatal case involving chlorpheniramine. Clin Toxicol 18: 941-943, 1981.
17. + channel block. J Biol Chem 277: 23587-23595, 2002. (Pubitemid 34952195)
18. Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 385: 77-80, 1996. (Pubitemid 26153472)
19. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Fujii T, Komemushi S, Itoh M, Sasaki H, Watanabe T, Yanai K. Differential cognitive effects of ebastine and (+)-chlorpheniramine in healthy subjects: correlation between cognitive impairment and plasma drug concentration. Br J Clin Pharmacol 53: 296-304, 2002. (Pubitemid 34226972)
20. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S, Ido T, Itoh M, Sasaki H, Watanabe T, Yanai K. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine. Br J Clin Pharmacol 52: 501-509, 2001.
21. Taglialatela M, Castaldo P, Pannaccione A, Giorgio G, Genovese A, Marone G, Annunziato L. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity, Clin Exp Allergy 29: 182-189, 1999. (Pubitemid 29333355)
22. Taglialatela M, Timmerman H, Annunziato L. Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci 21: 52-56, 2000. (Pubitemid 30100339)
23. Tie H, Walker BD, Valenzuela SM, Breit SN, Campbell TJ. The heart of psychotropic drug therapy. Lancet 355: 1825, 2000
24. Venkatraman N, O'Neil D, Hall AP. Life-threatening overdose with lamotrigine, citalopram, and chlorpheniramine. J Postgrad Med 54: 316-317, 2008.
25. + channel, erg. Circ Res 80: 261-268, 1996.
26. Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J 74: 230-241, 1998. (Pubitemid 28041752)